Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WARFALGORIT: Pharmacogenetic Warfarin Dosing in AF
NCT06789588Phase 3Enrolling by invitation
- Sponsor
- Universidade de Pernambuco
- Start
- Oct 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of warfarin in Atrial fibrillation (AFib), sponsored by Universidade de Pernambuco. Started Oct 2024; status: enrolling by invitation.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06789588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789588.